CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)

Hyungwoo Cho, Dok Hyun Yoon, Dong-Yeop Shin, Youngil Koh, Sung-Soo Yoon, Seok Jin Kim, Young Rok Do, Gyeong-Won Lee, Jae-Yong Kwak, Yong Park, Min Kyoung Kim, Hye Jin Kang, Jun Ho Yi, Kwai Han Yoo, Won Sik Lee, Byeong Bae Park, Jae Cheol Jo, Hyeon-Seok Eom, Hyo Jung Kim, Seong Hyun Jeong, Young-Woong Won, Byeong Seok Sohn, Ji-Hyun Kwon, Cheolwon Suh, Won Seog Kim

Cancer Research and Treatment. 2023;55(2):684-692. Published online 2023 January 2 DOI: https://doi.org/10.4143/crt.2022.1434

Cancer Research and Treatment. 2023;55(2):684-692

Link1

Link2 Link3

The role of high dose chemotherapy and autologous stem-cell transplantation in peripheral T-cell lymphoma: A review of the literature and new perspectives

Jean Yared, Amy Kimball

Cancer Treatment Reviews. 2013;39(1):51-59

Link1 Link2

A phase I/II, open-label, prospective, multicenter study to evaluate the efficacy and safety of lower doses of bortezomib plus busulfan and melphalan as a conditioning regimen in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation: The KMM103 study

Chang Ki Min, Sung-Soo Park

Clinical Lymphoma Myeloma and Leukemia. 2019;19(10):e216

Link1 Link2

Should Eligible Patients with T-Cell Lymphoma Receive High-Dose Therapy and Autologous Stem Cell Transplant in the Upfront Setting?

Carla Casulo, Steven Horwitz

Current Oncology Reports. 2010;12(6):374-382

Link1

Link2 Link3

Clinical Outcome of Upfront High Dose Chemotherapy Plus Total Body Irradiation with Autologous Hematopoietic Stem Cell Transplantation in Patients Associated with T-Cell Lymphoma

C.H. Maeng, S.J. Kim, E. Um, H.A. Jung

Annals of Oncology. 2014;25:iv332

Link1 Link2 Link3

Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients

Transfusion Medicine Reviews. 1998;12(1):77

Link1 Link2

The Comparative Pharmacoeconomic Analysis Of Using Plerixafor For Stem Cell Mobilization For Autologous Peripheral Stem Cell Transplantation For Non-Hodgkin’s Lymphoma Patients

V Krysanova, I Krysanov

Value in Health. 2015;18(7):A464

Link1 Link2

Reconstitution of the cellular immune response after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma

Nolte, Buhmann, Emmerich, Schendel, Hallek

British Journal of Haematology. 2000;108(2):415-423

Link1 Link2 Link3

Upfront Tandem Autologous Stem Cell Transplant Is Superior Than Autologous or Allogeneic Stem Cell Transplant After Failure of 1st Autologous Transplant in Patients with Multiple Myeloma

C. Bachier, A. Wong, P. Shaughnessy, C.F. LeMaistre

Biology of Blood and Marrow Transplantation. 2012;18(2):S295

Link1 Link2

Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: A case-controlled analysis of the EBMT Registry data

G. Liberti, R. Pearce, G. Taghipour, I. Majolino, A.H. Goldstone

Annals of Oncology. 1994;5:S151-S153

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.